Suppr超能文献

基于活性的光动力治疗敏化剂,具有优化的三重态特性,可实现对癌细胞的选择性和图像引导。

Activity-Based Photosensitizers with Optimized Triplet State Characteristics Toward Cancer Cell Selective and Image Guided Photodynamic Therapy.

机构信息

Department of Chemistry, Koç University, 34450 Istanbul, Turkey.

Department of Chemistry, Middle East Technical University (METU), 06800, Ankara, Turkey.

出版信息

ACS Appl Bio Mater. 2022 Jun 20;5(6):2754-2767. doi: 10.1021/acsabm.2c00202. Epub 2022 May 10.

Abstract

Activity-based theranostic photosensitizers are highly attractive in photodynamic therapy as they offer enhanced therapeutic outcome on cancer cells with an imaging opportunity at the same time. However, photosensitizers (PS) cores that can be easily converted to activity-based photosensitizers (aPSs) are still quite limited in the literature. In this study, we modified the dicyanomethylene-4-chromene (DCM) core with a heavy iodine atom to get two different PSs (DCM-I, I-DCM-Cl) that can be further converted to aPS after simple modifications. The effect of iodine positioning on singlet oxygen generation capacity was also evaluated through computational studies. DCM-I showed better performance in solution experiments and further proved to be a promising phototheranostic scaffold via cell culture studies. Later, a cysteine (Cys) activatable PS based on the DCM-I core (DCM-I-Cys) was developed, which induced selective photocytotoxicity along with a fluorescence turn-on response in Cys rich cancer cells.

摘要

基于活性的治疗性光动力治疗光敏剂在光动力治疗中极具吸引力,因为它们为癌细胞提供了增强的治疗效果,同时具有成像机会。然而,在文献中,能够轻易转化为基于活性的光敏剂(aPSs)的光敏剂(PS)核心仍然相当有限。在这项研究中,我们用重碘原子修饰了二氰基亚甲基-4-色烯(DCM)核心,得到了两个不同的 PS(DCM-I,I-DCM-Cl),它们可以通过简单的修饰进一步转化为 aPS。通过计算研究还评估了碘定位对单线态氧生成能力的影响。DCM-I 在溶液实验中表现出更好的性能,并通过细胞培养研究进一步证明是一种有前途的光治疗支架。后来,基于 DCM-I 核心开发了一种半胱氨酸(Cys)激活的 PS(DCM-I-Cys),它在富含 Cys 的癌细胞中诱导了选择性的光细胞毒性以及荧光开启响应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a9/9214761/aefbe005ad78/mt2c00202_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验